Elsa Renee Flores

@lab_gomes @MoffittNews Congratulations!!🍾

Honored to be recognized as the Research Educator of the Year. A PI’s real legacy isn’t just the papers they publish or the grants they win, it’s the people they mentor, the scientists, thinkers, and leaders who carry forward the values, curiosity, and rigor they helped cultivate

Had a memorable and exciting day celebrating Moffitt Cancer Center and the Moffitt Discovery and Innovation Center! Thank you to @TsoiKobus and @WhitingTurner !! @MoffittNews @Timadams2023 @PatrickHwuMD @HLeeMoffitt1

@NCIDirector @Olympics Congratulations!!

Proud dad moment: my daughter Julie is at the @Olympics competing in speed skating. The persistence and unwavering dedication it takes to reach this level is extraordinary. You've got this! 🇺🇸 nbcolympics.com/news/how-julie…

Thrilled to share our deconstruction of a p53 therapeutic response in #LUAD- a step toward drugging #undruggable #p53! Thanks to our amazing team! @wmx162005 @alyssamkaiser @kbieging @LabElsaFlores @MikeOzawa @MLadanyi @arati_rajeevan @rajnitin @simone_alma

This morning, I was thrilled to show off the progress on the Moffitt Discovery and Innovation Center at SPEROS. I can’t wait to make new discoveries with my colleagues using trans disciplinary approaches. Big thank you to @PatrickHwuMD @HLeeMoffitt1 @john Cleveland for the opportunity to lead this effort! @MoffittNews

James V. DeGregori, Emilia Lim, William Hill, and Kenneth Y. Tsai discussed "Early Events and Clonal Origins" in a plenary session at the AACR Special Conference on Cancer Evolution. #AACRevol25 @LimEmilia @DrWilliamHill @KYTsaiLab

A pioneer and an inspiration! In Conversation with Robert S. Langer | ACS Nano Medicine pubs.acs.org/doi/10.1021/ac…

Great day at Miles for Moffitt with my team Research Rangers and my daughter, Athena! @MoffittNews @PatrickHwuMD @HLeeMoffitt1

At #SITC25, Kenneth Tsai, MD (@KYTsaiLab), presents Phase II results showing a 57.7% pCR with neoadjuvant lenvatinib plus pembrolizumab in stage II–IV Merkel cell carcinoma. Responders show interferon and ANGPTL1 signaling; nonresponders show neural and E2F/MYC pathways with higher baseline Tregs. #MoffittSITC25

Highlights from the Jaeger Lab at SITC!

Great Moffitt basic science at SITC!

Live from #SITC25: Kenneth Tsai, MD (@KYTsaiLab) presents data showing that Pembrolizumab plus Levatinib demonstrated encouraging efficacy as neoadjuvant therapy for resectable clinical stage II-IV Merkel cell carcinoma.

Tomorrow at #SITC25: Kenneth Tsai, MD, PhD (@KYTsaiLab) presents a late-breaking abstract on the molecular and immunologic correlates of response in the phase II study of neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma. #MoffittSITC25 @sitcancer

Exciting application of bioengineering! Congratulations, @RanaFalahat @DrJamesMule! @MoffittNews

#ScienceSaturday ❓ Some people with multiple myeloma respond well to CAR T-cell therapy, but others relapse when the cancer finds ways to hide. Why does that happen, and how can we fix it? ➡️ Dr. Fabiana Perna and colleagues at Moffitt Cancer Center, found that one reason is that some myeloma cells don’t have enough of a target protein called BCMA, which CAR T cells need to find and attack the cancer. ➡️ To solve this, the team designed a new kind of CAR T cell that looks for a different target called SEMA4A. This protein is common on myeloma cells—even in patients whose cancer came back after BCMA-CAR T therapy. ➡️ In lab and mouse studies, these SEMA4A-CAR T cells destroyed myeloma cells that regular BCMA-CAR T cells couldn’t reach, showing promise for treating relapsed patients in the future. 🌟 This research could lead to next-generation cell therapies that keep multiple myeloma from coming back and help more patients stay cancer-free longer. @fabianaperna @MoffittNews 🔗 Read more in Cancer Cell: doi.org/10.1016/j.ccel…

@ProfGregSawyer MDI is looking great!

This weekend, I took a bike ride commute from Tampa to Speros with my boys. It was a beautiful ride and a total pleasure. So inspiring to see how the campus is coming together!

Congratulations @LabKissil ! Exciting new model of lung cancer! @MoffittNews @PatrickHwuMD @KYTsaiLab

Moffitt Study Uncovers New Mechanism of Immunotherapy Resistance | Moffitt moffitt.org/newsroom/news-… Exciting research from the Tsai lab published in Nature!